133 related articles for article (PubMed ID: 6490047)
21. [Suppression of myocardial lipid peroxidation during preventive treatment of transitory coronary insufficiency with myophedrine].
Litvitskiĭ PF; Kogan AKh; Kudrin AN; Luk'ianova LO; Ol'binskaia LI
Farmakol Toksikol; 1981; 44(3):303-7. PubMed ID: 7286187
[TBL] [Abstract][Full Text] [Related]
22. [Correction of extracardiac effects on the heart as a method of treating ischemic heart disease].
Komarov FI; Ol'binskaia LI; Litvitskiĭ PF; Bragina GI
Farmakol Toksikol; 1982; 45(3):53-9. PubMed ID: 6284550
[No Abstract] [Full Text] [Related]
23. Oral oxyfedrine on left ventricular performance in patients of ischaemic heart disease.
Puri VK; Mehrotra A; Agarwal SK; Hasan M
J Assoc Physicians India; 1985 Apr; 33(4):269-71. PubMed ID: 4030673
[No Abstract] [Full Text] [Related]
24. [Effectiveness of adrenergic beta 1 receptor agonists in the correction of hemodynamics in patients with chronic cor pulmonale].
Gavrisiuk VK; Morskaia ND; Iachnik AI; Morozova NA; Iakhnitsa TV
Klin Med (Mosk); 1990 Jan; 68(1):60-3. PubMed ID: 2186208
[No Abstract] [Full Text] [Related]
25. [Long-term therapy of angina pectoris. Evaluation of the effectiveness and tolerance of oxyfedrine in ambulatory patients].
Schieffer H; Sternitzke N
Fortschr Med; 1984 May; 102(19):551-6. PubMed ID: 6429021
[TBL] [Abstract][Full Text] [Related]
26. [The action of oxyfedrine on haemodynamics, inotropism and blood perfusion of the partially ischaemic myocardium after digoxin premedication. Studies on anaesthetized dogs (author's transl)].
Hahn N; Raqué B; Holst A; Henn I; von Randow H; Malotki D; Oehr P; Felix R
Arzneimittelforschung; 1981; 31(3):410-4. PubMed ID: 7194664
[TBL] [Abstract][Full Text] [Related]
27. [Effects of the partial beta-adrenergic receptor agonist, oxyfedrine, on regional myocardial blood flow and left ventricular function in patients with coronary artery disease].
Dirschinger J; Fleck E; Rudolph W
Herz; 1982 Dec; 7(6):351-7. PubMed ID: 7160821
[No Abstract] [Full Text] [Related]
28. [Effect of nonachlazine and oxyphedrin on a focus of myocardial ischemia].
Chichkanov GG; Bogolepov AK
Biull Eksp Biol Med; 1978 Dec; 86(12):691-4. PubMed ID: 728611
[TBL] [Abstract][Full Text] [Related]
29. Left ventricular function in acute myocardial infarction before and after oxyfedrine.
Agrawal BV; Agrawal VK; Somani PN
J Indian Med Assoc; 1985 Jan; 83(1):11-4. PubMed ID: 4008944
[No Abstract] [Full Text] [Related]
30. [Study of cardiac excitation and conduction after administration of oxyfedrine. Preliminary observations].
Franchi F; Padeletti L; Michelucci A; Brat A
Boll Soc Ital Cardiol; 1977; 22(2):151-7. PubMed ID: 618199
[No Abstract] [Full Text] [Related]
31. [Effect of ildamen on the heart conduction system in ischemic heart disease patients].
Shilov AM; Borisov VG
Farmakol Toksikol; 1987; 50(5):34-6. PubMed ID: 2891566
[TBL] [Abstract][Full Text] [Related]
32. [Preliminary observations on the use of oxyfedrine in the therapy of angina pectoris].
Di Lorenzo M; Puddu V
Minerva Cardioangiol; 1975 Jan; 23(1):3-6. PubMed ID: 806853
[No Abstract] [Full Text] [Related]
33. Oxyfedrine as an antianginal agent.
Parratt JR
Lancet; 1981 Feb; 1(8217):441. PubMed ID: 6110066
[No Abstract] [Full Text] [Related]
34. A new coronary cardio-active compound in angina pectoris.
Kundu SC; De TK; Majumdar S; Bhattacherjee TD; Mukerjee AB
J Indian Med Assoc; 1975 Sep; 65(5):136-43. PubMed ID: 765401
[No Abstract] [Full Text] [Related]
35. [Effects of oxyfedrine on myocardial infarct size following coronary artery occlusion in rats (author's transl)].
Chiariello M; Brevetti G; Petillo F; Ferro G; Giasi M; Condorelli M
G Ital Cardiol; 1981; 11(3):373-9. PubMed ID: 6116640
[No Abstract] [Full Text] [Related]
36. Regional myocardial blood flow and segmental wall function after oxyfedrine administration in the ischaemic porcine heart.
Schamhardt HC; Verdouw PD; van der Hoek TM; Saxena PR
Cardiovasc Res; 1980 Aug; 14(8):451-7. PubMed ID: 7438148
[No Abstract] [Full Text] [Related]
37. [Use of coronaroactive agents with beta-stimulating effect in ischemic heart disease].
Kukes VG; Buianov VV; Semenov VN; Abugov AM; Borovkov AI
Kardiologiia; 1976 Apr; 16(4):88-93. PubMed ID: 16157
[TBL] [Abstract][Full Text] [Related]
38. Clinical experiences with oxyfedrine in patients with angina pectoris.
Raftery EB; Whittington JR
Herz; 1982 Dec; 7(6):358-65. PubMed ID: 6761258
[No Abstract] [Full Text] [Related]
39. [Effect of oxyphedrin (Ildamen) on the blood level of nonesterified long-chain fatty acids].
Kaliciński A; Proniewska W; Sydor A
Pol Tyg Lek; 1977 Jun; 32(25):953-6. PubMed ID: 882437
[No Abstract] [Full Text] [Related]
40. [Reperfusion damages to the heart in acute transitory coronary failure and their prevention with myophedrin].
Vasilevskaia TA; Litvitskiĭ PF
Biull Eksp Biol Med; 1985 Jul; 100(7):97-100. PubMed ID: 4016248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
